Shengyiyao Overview
- Year Founded
-
2001
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
1
Shengyiyao General Information
Description
Developer and producer of innovative drugs for the treatment of malignant tumors. The company cooperates with hundreds of hospitals on treatment projects and focuses on the use of Sodium alginate to coat danazol for the treatment of gynecological benign tumors.
Contact Information
Corporate Office
- Building 2, Building 12, No. 26, Yongwang West Road
- Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District
- Beijing, 102600
- China
Corporate Office
- Building 2, Building 12, No. 26, Yongwang West Road
- Daxing Biomedical Industry Base, Zhongguancun Science and Technology Park, Daxing District
- Beijing, 102600
- China
Shengyiyao Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 06-Jul-2021 | Completed | Generating Revenue |
Shengyiyao Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Chiron Ventures | Venture Capital | Minority |
Shengyiyao FAQs
-
When was Shengyiyao founded?
Shengyiyao was founded in 2001.
-
Where is Shengyiyao headquartered?
Shengyiyao is headquartered in Beijing, China.
-
What industry is Shengyiyao in?
Shengyiyao’s primary industry is Drug Discovery.
-
Is Shengyiyao a private or public company?
Shengyiyao is a Private company.
-
What is Shengyiyao’s current revenue?
The current revenue for Shengyiyao is .
-
Who are Shengyiyao’s investors?
Chiron Ventures has invested in Shengyiyao.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process